|Bid||0.00 x 900|
|Ask||0.00 x 800|
|Day's range||145.25 - 147.25|
|52-week range||120.40 - 158.34|
|Beta (5Y monthly)||0.97|
|PE ratio (TTM)||14.29|
|Earnings date||02 Feb 2023|
|Forward dividend & yield||2.64 (1.80%)|
|Ex-dividend date||17 Jan 2023|
|1y target est||150.73|
Quest Diagnostics (DGX) ramps up investments to accelerate growth in the base business, particularly in advanced diagnostics and direct-to-consumer testing.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Investors are optimistic about Quest Diagnostics (DGX) on strong growth in the base business.